99
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Drug Treatment Effectiveness: An Examination of Conceptual and Policy Issues

&
Pages 1629-1657 | Published online: 03 Jul 2009

References

  • Acker C. J. Stigma or legitimization? A historical examination of the social potentials of addiction disease models. J. Psychoactive Drugs 1993; 25(3)193–205
  • American Psychological Association, Task Force on Psychological Intervention Guidelines. American Psychological Association, Washington, DC 1994, Report
  • Anglin M. D., Hser Y.-I. Treatment of drug abuse. Drugs and Crime, M. Tonry, J. Q. Wilson. University of Chicago Press, Chicago 1990; 393–460
  • Apsler R. Is drug abuse treatment effective?. Am. Enterprise March/April, 1994; 5(2)46–53
  • Apsler R., Harding W. M. Cost-effectiveness analysis of drug abuse treatment: Current status and recommendations for future research. Background Papers on Drug Abuse, Financing and Services Research. National Institute on Drug Abuse, Rockville, MD 1991, (NIDA Drug Abuse Services Research Series 1, pp. 58–81)
  • Bennett W., Diiulio J. J., Walters J. P. Body Count: Moral poverty and How to Win America's War Against Crime and Drugs. Simon & Schuster, New York 1996
  • Berg W. E. Evaluation of community-based drug abuse treatment programs: A review of the research literature. The Addiction Process: Effective Social Work Approaches, E. M. Freeman. Longman, New York 1992; 81–95
  • Bernacki P. Pathways from Heroin Addiction: Recovery Without Treatment. Temple University Press, Philadelphia 1986
  • Brickman P., Rabinowitz V. C., Karuza J., Coates D., Cohen E., Kidder L. Models of helping and coping. Am. Psychol. 1982; 37(4)368–384
  • Brower K. J., Blow F. C., Beresford T. P. Treatment implications of chemical dependency models: An integGative approach. J. Subst. Abuse Treat. 1989; 6: 147–157
  • Brown B. J., Jr. Statistical controversies in the design of clinical trials: Some personal views. Controlled Clin. Trials 1980; 1: 13–27
  • Brown B. S. Treatment of non-opiate dependency: Issues and outcomes. Research Advances in Alcohol and Drug Problems, R. G. Smart, F. B. Glaaser, Y. Israel, et al. Plenum Press, New York 1984; Vol. 8
  • Buscema M. Artificial Neural Networks and Complex Social Systems: Theory, Models and Applications [special issue]. Subst. Use Misuse 1998; 33(1–3)1–916
  • Chow S. L. Statistical Significance: Rationale, Validity and Utility. Sage Publications Inc, Thousand Oaks, CA 1996
  • Cochrane A. L. Effectiveness and Efficiency: Random Reflections on Health Services. Nuffield Provincial Hospitals Trust, London 1972
  • Cook T. D., Campbell D. T. Quasi-Experimentation: Design and Analysis Issues for Field Settings. Houghton Mifflin Company, Boston 1979
  • Research on the Treatment of Narcotics Addiction: State of the Art, J. R. Cooper, F. Altman, B. S. Brown, D. Czechowicz. National Institute on Drug Abuse, U.S. Department of Health and Human Services, Rockville, MD 1983, (NIDA Treatment Research Monograph)
  • Courtwright D. T. A century of American narcotic policy. Treating Drug Problems, D. R. Gerstein, H. J. Harwood. National Academy Press, Washington, DC 1992; Vol. 2
  • De Leon G., Inciardi J. A., Martin S. M. Residential drug abuse treatment research: Are conventional control designs appropriate for assessing treatment effectiveness?. J. Psychoactive Drugs 1995; 27(1)85–91
  • Falco M. The Making of a Drug-Free America: Programs that Work. Time Books, New York 1992
  • Gerstein D. R., Harwood H. J. Treating Drug Problems. National Academy Press, Washington, DC 1990; Vol. 1
  • Gray B. H. The legislative battle over health services research. Health Affairs 1992; 11(4)38–66
  • Hansen N. B., Lambert M. J. Clinical significance: An overview of methods. J. of Mental Health 1996; 5(1)17–24
  • Hubbard R. L. Evaluation and treatment outcome. Substance Abuse: A Comprehensive Textbook, 2nd ed., J. H. Lowinson, P. Ruiz, R. B. Millman, J. G. Langrod. Williams & Wilkins, Baltimore 1992; 596–611
  • Jacobson N. S., Follette W. C., Revenstrof D. Psychotherapy outcome research: Methods for reporting variability and evaluating clinical significance. Behav. Ther. 1984; 15: 336–352
  • Jacobson N. S., Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J. Consult. Clin. Psychol. 1991; 59(1)12–19
  • Kamerow D. B. Before and after guidelines. J. Fam. Pract. 1997; 44(4)344–346
  • Kazdin A. E., Wilson G. Criteria for evaluating psychotherapy. Arch. Gen. Psychiatry 1978; 35: 407–416
  • Kingdon J. W. Agenda. Alternatives. and Public Policies. Harper Collins Publishers, New York 1984
  • Kleber H. D. Treatment of drug dependence: What works. Int. Rev. Psychiatry 1989; 1: 81–100
  • Krauthammer C. Drug treatment hustle. February 20, 1997, Washington Post
  • Landry M. J. Overview of Addiction Treatment Effectiveness. Substance Abuse and Mental Health Services Administration, Rockville, MD 1995
  • Lennard H. L., Allen S. D. The treatment of drug addiction: Toward new models. Int. J. Addict. 1973; 8(3)521–535
  • Alcohol. Drug Abuse Weekly July 15, 1996; 8(28)3, Leshner says data back needle exchange; more studies to come
  • Lindblom C. E., Woodhouse E. J. The Policy-Making Process, 3rd ed. Prentice-Hall, Inc., Englewood Cliffs, NJ 1993
  • MacCoun R., Caulkins J. Examining the behavioral assumptions of the national drug control strategy. Drug Policy and Human Nature: Psychological Perspectives on the Prevention, Management, and Treatment of Illicit Drug Abuse, W. Bickel, R. DeGrandpre. Plenum Press, New York 1996; 177–197
  • McLellan A. T., O'Brien C. P., Metzger D., Alterman A. I., Cornish J., Urschel H. How effective is substance abuse treatment: Compared to what?. Addictive States, C. P. O'Brien, J. H. Jaffe. Raven Press, New York 1992; 231–252
  • McLellan A. T., Woody G. E., Metzger D., McKay J., Durrell J., Alterman A. I., O'Brien C. P. Evaluating the effectiveness of addiction treatments: Reasonable expectations, appropriate comparisons. Millbank Quart. 1996; 74(1)51–85
  • Malbin M. J. Unelected Representatives: Congressional Staff and the Future of Representative Government. Basic Books, New York 1980
  • Martin G. Treating Alcohol and Drug Problems in Ontario: A Vision for the 90's. Addiction Research Foundation, Toronto 1990, Report submitted to the Minister Responsible for the Ontario Provincial Anti-Drug Strategy
  • National Association Of State Alcohol And Drug Abuse Directors. Treatment Works: The Tragic Cost of Undervaluing Treatment in the “Drug War.”. National Association of State Alcohol and Drug Abuse Directors, Washington, DC 1990
  • O'Brien C. P., McLellan A. T. Myths about the treatment of addiction. Lancet 1996; 347: 237–240
  • OFFICE OF TECHNOLOGY ASSESSMENT. Identifying Health Technologies that Work: Searching for Evidence. Office of Technology Assessment, U.S. Congress, Washington, DC 1994
  • Peele S. Diseasing of America: Addiction Treatment Out of Control. Lexington Books, Lexington, MA 1989
  • Peele S. Assumptions about drugs and the marketing of drug policies. Drug Policy and Human Nature, W. K. Bickel, R. J. DeGrandpre. Plenum Press, New York 1996; 199–220
  • Peele S., Brodsky A. The Truth About Addiction and Recovery. Simon and Schuster, New York 1991
  • Persons J. B. Psychotherapy outcome studies do not accurately represent current models of psychotherapy. Am. Psychol. 1991; 46(2)99–106
  • Pincus T. Consecutive patient questionnaire databases: A complementary alternative. J. NIH Res. 1997; 9(9)32
  • Roper W. L., Winkenwerder W., Hackbarth G. M., Krakauer H. Effectiveness in health care. An initiative to evaluate and improve medical practice. N. Engl. J. Med. 1988; 319(18)1197–1202
  • Sechrest L., Yeaton W. H. Magnitudes of experimental effects in social science research. Eval. Rev. 1982; 6(5)579–600
  • Seligman M. E. The effectiveness of psychotherapy: The Consumer Reports study. Am. Psychol. 1995; 50(12)965–974
  • Single E. Defining harm reduction. Drug Alcohol Rev. 1995; 14: 287–290
  • Sisk J. E., Hatziandreu E. J., Hughes R. The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection. Office of Technology Assessment, U.S. Congress, Washington, DC 1990, (AIDS-Related Issues Background Paper 6; OTA-BP-H-73)
  • Strupp H. The tripartite model and the Consumer Reports study. Am. Psychol. 1996; 51(10)1017–1024
  • Swindle R. W., Peterson K. A., Paradise M. J., Moos R. H. Measuring substance abuse program treatment orientations: the Drug and Alcohol Program Treatment Inventory. J. Subst. Abuse 1995; 7(1)61–78
  • Tanenbaum S. J. Knowing and acting in medical practice: The epistemological politics of outcomes research. J. Health Polities 1994; 19(1)27–44
  • Tingey R. C., Lambert M. J., Burlingame G. M., Hansen N. B. Assessing clinical significance: Proposed extensions to method. Psychother. Res. 1996; 6(2)109–123
  • Weisz J. R., Weiss B., Donenberg G. R. The lab versus the clinic: Effects of child and adolescent psychotherapy. Am. Psychol. 1992; 47(12)1578–1585
  • Wells K. B. Treatment research at the crossroads: The scientific interface of clinical trials and effectiveness research. Am. J. Psychiatry 1999; 156(1)5–10
  • Wilensky H. L. Social science and the public agenda: Reflections on the relation of knowledge to policy in the United States and abroad. J. Health Polities Policy Law 1997; 22(5)1241–1265

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.